Navigation Links
Cara Therapeutics Secures $12.3 Million in Series C Extension Financing
Date:7/24/2008

tements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements relating to the therapeutic applications of CR845 and about Cara's strategy, technologies, pre-clinical and clinical programs, and ability to identify and develop drugs, as well as other statements that are not historical facts. Actual events or results may differ materially from Cara's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Cara's research and clinical studies and Cara's ability to obtain additional financing. These forward-looking statements represent Cara's judgment as of the date of this release. Cara disclaims any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Cara Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 On January 20th, 2010, ... for Medical Publication Professionals (ISMPP) will be held ... UK. More than 100 attendees are expected at ... publication professionals, editors, publishers, medical writers and medical ... publications and the impact of guidelines and regulations ...
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... -- Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") ... with The Scripps Research Institute ("Scripps") by entering ... genome of Dyadic,s patented and proprietary C1 fungus ... the successful relationship between the two organizations which ... to annotate the C1 genome for the first ...
Breaking Biology Technology:Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... a group of entrepreneurs in Fribourg, Switzerland, entitled Dancing with Elephants. ... productively with the giants of the industry. Then, this summer, I ... European conference, Innovate!Europe. , ,That, I thought, would be the end ... clever title before someone catches on? Turns out, you can use ...
... - Quintessence Biosciences , a biopharmaceutical company developing ... EVade cancer treatments, has been selected for preclinical testing ... pending a favorable preclinical safety assessment, it would submit ... an investigational new drug application in late 2007, with ...
... If you dropped the word sustainability in a crowd ... would have pegged you as an aging hippie, then ... bikes to work. , ,Today, sustainability still carries some ... around to talk because there's no avoiding a rational ...
Other Biology Technology:Dancing with elephants requires nifty footwork 2Dancing with elephants requires nifty footwork 3Dancing with elephants requires nifty footwork 4Re-engineering our economy to be sustainable and profitable 2Re-engineering our economy to be sustainable and profitable 3Re-engineering our economy to be sustainable and profitable 4
(Date:12/14/2009)... renewable fuel that could help wean the nation from ... compared with gasoline, especially in winter, according to a ... production from both gasoline and E85, a blend of ... greater in warm sunny weather than during the cold ... sunlight contribute to ozone formation. But E85 produces different ...
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3IUPUI researchers tackle protein mechanisms behind limb regeneration 2Tool use in an invertebrate: The coconut-carrying octopus 2Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 1Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 2Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 3Hand washing Compliance Computer Auto Log on Log off and Patient Fall detection are Enabled by Real Time Location System 28RTLS 29 with Sub room Lo 14890 4iSirona Announces Go live at University Hospitals in Cleveland 14887 1iSirona Announces Go live at University Hospitals in Cleveland 14887 2iSirona Announces Go live at University Hospitals in Cleveland 14887 3Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 1Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 2Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 3
... component of DNA that can both stimulate and suppress ... hope for treating cancer and infection, Medical College of ... increase inflammation, part of the body,s way of eliminating ... of the enzyme indoleamine 2,3 dioxygenase, or IDO, an ...
... 27, 2009 A new study by researchers at ... Affairs has found that global climate change may lead ... the western United States, which could create unprecedented ecological ... At the same time, global warming may enable other ...
... have found a surprising link between brain iron ... conditions ranging from autism to major depression., Appearing ... of Sciences this week, the study by ... utility of a powerful in silico approach for ...
Other Biology News:DNA component can stimulate and suppress the immune response 2Climate change's impact on invasive plants in Western US may create restoration opportunities 2Climate change's impact on invasive plants in Western US may create restoration opportunities 3Climate change's impact on invasive plants in Western US may create restoration opportunities 4Researchers iron out new role for serotonin 2
... Comments: Ab-1 stains tumor cells ... not other type of germ cell tumors like ... immature teratoma are positive. Luminal and endocrine cells ... lobules of breast are also positive. ...
... Endogenous potent vasoconstrictor peptide. Displays selectivity ... vascular tonus. ET-1, ET-2, and ET-3 are ... ET-2 and ET-3 are similar to ET-1, ... acids, respectively. All three isopeptides produce strong ...
HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... siRNA Custom Synthesis Service provides ... RNA to knockdown any gene. ... RNA base pairs with terminal ... or other lengths of your ...
Biology Products: